Filter
718
Filtered Results: 718
Text search:
Angola
Featured
Recommendations
66
New Publications
156
Language
Document type
No document type
352
Studies & Reports
164
Guidelines
79
Strategic & Response Plan
37
Manuals
24
Fact sheets
24
Situation Updates
9
Online Courses
8
Brochures
7
Infographics
7
Training Material
5
Resource Platforms
1
Videos
1
Countries / Regions
Angola
108
Mozambique
102
Brazil
52
Africa
51
Global
50
Guinea-Bissau
48
Congo, Democratic Republic of
41
Zambia
20
Portugal
18
Namibia
17
East and Southern Africa
17
West and Central Africa
14
Uganda
13
South Africa
12
Russia
12
Liberia
10
Rwanda
10
Latin America and the Carribbean
10
Sierra Leone
9
Somalia
9
Syria
9
Indonesia
9
Malawi
9
Middle East and North Africa
9
Nigeria
8
Tanzania
8
Ethiopia
7
Kenya
7
Central African Republic
7
Zimbabwe
6
Germany
6
China
6
Eswatini/ Swaziland
6
Lesotho
6
Guinea
5
Senegal
5
India
5
Yemen
5
Ghana
4
South Sudan
4
Chad
4
Botswana
4
Sri Lanka
4
Vietnam
4
Cameroon
3
Niger
3
Malaysia
3
Burundi
3
Western and Central Europe
3
Southern Africa
3
Côte d’Ivoire / Ivory Coast
2
Philippines
2
Nepal
2
Pakistan
2
Afghanistan
2
Turkey
2
Thailand
2
Bangladesh
2
Cape Verde
2
Madagascar
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Italy
2
Iran
2
Japan
2
Denmark
2
Burkina Faso
1
Mali
1
Togo
1
Haiti
1
Iraq
1
Egypt
1
Papua New Guinea
1
Benin
1
Vanuatu
1
Peru
1
Switzerland
1
Hungary
1
Ukraine
1
Colombia
1
Ecuador
1
Greece
1
Mexico
1
Myanmar / Burma
1
Solomon Islands
1
Venezuela
1
Poland
1
North Korea
1
Mauritius
1
Spain
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
235
Clinical Guidelines
58
Public Health
46
Key Resources
43
Women & Child Health
30
Capacity Building
17
Pharmacy & Technologies
12
Toolboxes
COVID-19
101
HIV
83
Rapid Response
36
Ebola
34
NTDs
34
Disability
28
Planetary Health
25
Mental Health
23
TB
21
Refugee
17
Health Financing Toolbox
17
Natural Hazards
16
Global Health Education
15
Polio
14
Caregiver
11
Conflict
10
Specific Hazards
10
AMR
9
Pharmacy
8
NCDs
6
Zika
5
Cholera
3
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.
Conflict, climate change, the COVID-19 pandemic, and the economic effects of the Ukraine crisis are interacting to create new and worsen existing hunger hotspots, reversing the gains families had made to escape poverty.
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
January 2020 to December 2021
The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
Loss and damage is an urgent concern, driven by the increasingly harmful effects of climate change. Communities are experiencing new types and forms of climate impact, of higher frequency and intensity, which they are not equipped to handle. These impacts compel vulnerable communities to migrate to ...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
La Stratégie de riposte face à la résistance aux antipaludiques en Afrique est un document technique de sensibilisation qui se fonde sur les bases factuelles les plus solides dont on dispose et vise à réduire au maximum la menace et l’impact de la résistance aux antipaludiques de Plasmodium ...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
